| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/01/2009 | US7582768 Zoledronic acid crystal forms, zoledronate sodium salt crystal forms, amorphous zoledronate sodium salt, and processes for their preparation |
| 09/01/2009 | US7582767 N-[7-(4-piperidinyl)oxy-1-benzofuran-5-yl]-5-hydroxymethyl-2-methoxybenzenesulfonamide; the prophylaxis and treatment of medical conditions relating to obesity, type II diabetes, CNS disorders, to achieve reduction of body weight and/or body weight gain |
| 09/01/2009 | US7582766 DNA replication that interfere with the E1-E2-DNA complex during initiation of DNA replication; (N-benzyl)phenylacetamides or N-benzyl-N'-phenyl ureas |
| 09/01/2009 | US7582765 Aryl aniline β2 adrenergic receptor agonists |
| 09/01/2009 | US7582762 Salt and crystalline forms of (2R)-anti-5-{3-[4-(10,11-difluoromethanodibenzosuber-5-YL)piperazin-1-YL]-2-hydroxypropoxy}quinoline |
| 09/01/2009 | US7582760 Benzimidazolone and dihydroindolone derivatives and uses thereof |
| 09/01/2009 | US7582758 producing cyclic phosphonic acid diesters prodrugs, used to improve the oral bioavailability; by reacting a chiral 1,3-diol and an activated phosphonic acid in the presence of a Lewis acid; Adefovir drug target delivery to liver |
| 09/01/2009 | US7582756 3-(4-amidopyrrol-2-ylmethylidene)-2-indolinone derivatives as protein kinase inhibitors |
| 09/01/2009 | US7582755 Cyanopyrrole-containing cyclic carbamate and thiocarbamate biaryls and methods for preparing the same |
| 09/01/2009 | US7582754 For treating hepatitis C virus infections; polymerase inhibitors |
| 09/01/2009 | US7582747 siRNA targeting inner centromere protein antigens (INCENP) |
| 09/01/2009 | US7582746 Short interfering RNA sequences for use as therapeutic tools in treatment of cancer, diabetes and nervous system disorders |
| 09/01/2009 | US7582745 Compositions and methods for inhibiting expression of Nav1.8 gene |
| 09/01/2009 | US7582744 Chemically modified oligonucleotides |
| 09/01/2009 | US7582681 Consisting of two or more straight chain 1,2-alkanediols having chain lengths that (i) are different and (ii) in each case are in the range of 5 to 10 C atoms; exhibit a synergistically intensified antimicrobial effect, at least against selected germs; useful in preservation of perishable products |
| 09/01/2009 | US7582680 Methods and compositions for treating mammalian spinal cord injuries |
| 09/01/2009 | US7582679 Contains a solid ibuprofen free acid and a solid ibuprofen alkali salt, and is characterized in that at least 90% of the weight of the solid ibuprofen concentrate is ibuprofen free acid and ibuprofen alkali salt; immediate release analgesics |
| 09/01/2009 | US7582678 Use of branched-chain fatty acids and derivatives thereof for the treatment of pain |
| 09/01/2009 | US7582677 Cosmetics and/or skin protective agents; derived from wood materials in high concentration |
| 09/01/2009 | US7582676 2-phenylpyran-4-one derivatives as selective COX-2 inhibitors |
| 09/01/2009 | US7582675 Flavonoid compound and process for producing the same |
| 09/01/2009 | US7582674 Nutraceutical compositions and use thereof |
| 09/01/2009 | US7582673 Bissulfonamide compounds as agonists of GalR1, compositions, and methods of use |
| 09/01/2009 | US7582672 Compounds for the treatment of CRTH2-mediated diseases and conditions |
| 09/01/2009 | US7582671 Therapeutic use of N-(1H-indolyl)-1H-indole-2-carboxamide derivatives |
| 09/01/2009 | US7582670 methods of treating inflammatory-related diseases associated with pro-inflammatory cytokine expression and/or reduced expression of anti-inflammatory cytokines. The method typically comprises administration of one or more compounds selected from isoindigo, indigo, indirubin, or derivatives thereof |
| 09/01/2009 | US7582669 Aminoindazole derivatives as medicaments and pharmaceutical compositions including them |
| 09/01/2009 | US7582668 to treat cellular proliferative diseases, hyperplasias, solid tumor, cardiac hypertrophy, immune disorders and inflammation; modulators of one or more mitotic kinesins; N-(2-(2-dimethylamino-acetylamino)-1-{4-[8-(1-hydroxy-ethyl)-imidazo[1,2-a]pyridin-2-yl]-benzyl}-ethyl)-3-chloro-4-isopropoxy-benzamide |
| 09/01/2009 | US7582666 Substituted 2-oxo-3-phenyl-5-carbonylaminomethyl-1,3-oxazolines and their use as anticoagulant and antithrombotics |
| 09/01/2009 | US7582665 Heterocyclic sulfur compounds and/or prodrugs administered for prophylaxis of thrombocytopenia, anemia or blood disorders |
| 09/01/2009 | US7582664 Acylaminothiazole derivatives, preparation method thereof and use of same in therapeutics |
| 09/01/2009 | US7582663 p-(2-alkoxy-2-acylethyl)biphenyl compounds; 1-[4'-(2-ethoxy-3-morpholin-4-yl-3-oxopropyl)biphenyl-3-yl]-3-heptyl-1-methylurea; human or veterinary medicine: dermatology, cardiovascular diseases, immune diseases,; lipid metabolism diseases; Peroxisome Proliferator-Activated Receptor modulator |
| 09/01/2009 | US7582662 Body weight gain inhibitor |
| 09/01/2009 | US7582661 Antagonists of the chemokine receptor 9 (CCR9); inhibit TECK ligand; antiinflammatory agents and immunoregulators; inflammatory bowel disease; 2-Amino-5-chloro-phenyl)-(3-methyl-pyridin-4-yl)-methanone |
| 09/01/2009 | US7582660 2-thio-substituted imidazole derivatives and their use in pharmaceutics |
| 09/01/2009 | US7582659 effective against aerobic and anerobic pathogens such as multi-resistant staphylococci, streptococci and enterococci; 1-[5(R)-3-[4-[2-[(1 alpha ,5 alpha ,6 beta )-6-Cyano-3-azabicyclo[3.1.0]hexan-6-yl]pyridin-5-yl]-3-fluorophenyl]-2-oxooxazolidin-5-ylmethyl]-1,2,3-triazole; side effect reduction |
| 09/01/2009 | US7582658 Bicyclic compound |
| 09/01/2009 | US7582657 Vanilloid receptor ligands and their use in treatments |
| 09/01/2009 | US7582656 Guanidine derivatives and therapeutic uses thereof |
| 09/01/2009 | US7582655 Antineoplastic compounds |
| 09/01/2009 | US7582654 Antiarrhythmia agents, treating gastrointensinal disorder, gastroesophageal reflux, chronic obstructive pulmonary disease, diabetes;N-cotnaining heterocyclic compound with carbamate or amide groups and indazole ring |
| 09/01/2009 | US7582653 Mercaptophenyl naphthyl methane compounds and synthesis thereof |
| 09/01/2009 | US7582652 Kinase inhibitors |
| 09/01/2009 | US7582651 Pyrrolopyridine derivative and use thereof |
| 09/01/2009 | US7582650 9-(8-Aza-bicyclo[3.2.1]oct-3-ylidene)-9H-xanthene-4-carboxylic acid amide; veterinary formulation for treating mild to severe pain |
| 09/01/2009 | US7582649 Hydroxy alkyl substituted 1,3,8-triazaspiro[4.5]decan-4-one derivatives useful for the treatment of ORL-1 receptor mediated disorders |
| 09/01/2009 | US7582648 Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds |
| 09/01/2009 | US7582647 2-((4,6-dimethoxy)pyrimidin-2-yl-),3-(methoxy-), 3,3-(diphenyl)propionic acid; antihypotensive agents; pulmonary hypertension, mycocardial necrosis; renal failure; brain disorders; antispasmodic agents; antiischemic agents; coagulants; asthma; atherosclerosis; restenosis; Raynaud's syndrome |
| 09/01/2009 | US7582645 Pyrimidine derivatives for treatment of hyperproliferative disorders |
| 09/01/2009 | US7582644 Pyrimidyl sulphone amide derivatives as chemokine receptor modulators |
| 09/01/2009 | US7582643 Asthma therapy; antiallergens; antiinflammatory agents |
| 09/01/2009 | US7582642 4-{9-Isopropyl-6-[(pyridin-3-ylmethyl)-amino]-9H-purin-2-ylamino}-2-methyl-hexan-3-ol;antiproliferative agents; viricides; alopecia; strokes; central nervous system diorders; neurodegenerative diseases; antidiabetic agents; mitosis; cyclin dependent kinase inhibitors; protein kinase inhibitors |
| 09/01/2009 | US7582641 Gyrase inhibitors and uses thereof |
| 09/01/2009 | US7582640 3-[[5-Ethyl-6-[4-(1,2,3,4-tetrahydro-1,8-naphthyridin-7-yl)-1-piperidinyl]-4-pyrimidinyl]amino]-N-[(phenylmethoxy)carbonyl]alanine; osteoporois; restenosis; arteriosclerosis; cell adhesion/bone bioresorption inhibiters; cardiovascular disorders; antitumor agents; anticarcinogenic agents; bone disorders |
| 09/01/2009 | US7582639 Thiocolchicine dimers linked through linear aliphatic amido or amido-ureido bridge; antiproliferative, antiinflammatory, antiarthritic, antiviral agents; cytotoxicity; piperazinedicarboxylic acid bis-(N-deacetylthiocolchicine) amide derivatives; acts on cells expressing multidrug resistant phenotypes |
| 09/01/2009 | US7582638 With improved potency and greater bioavailability; 1-{1-[1-(1-Methyl-cyclopropanecarbonyl)-piperidin-4-yloxy]-isoquinolin-4-yl}-3-[5-(1-methyl-cyclopropyl)-2-p-tolyl-2H-pyrazol-3-yl]-urea; antimetastasis and antineoplastic agents, rheumatoid arthritis |
| 09/01/2009 | US7582637 to treat diseases mediated by kinase activity; for example: leukemia or myeloproliferative disorder |
| 09/01/2009 | US7582636 6-{4-[2 (4-tert-Butyl-phenyl)-imidazo[1,2-a]pyridin-5-yl]-piperazin-1-ylmethyl}- quinoxaline;oral delivery; bioavailability; luteinizing hormone releasing hormone) receptor antagonists; antifertility agents; hormone inhibitors |
| 09/01/2009 | US7582635 Benzoazolylpiperazine compounds inhibition of gluatmate receptors; for treatment of urinary incontinence, ulcers, irritable-bowel syndrome, inflammatory-bowel disease, addictive disorders, Parkinson's disease, parkinsonism, anxiety, epilepsy; kits |
| 09/01/2009 | US7582634 7-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor |
| 09/01/2009 | US7582633 Azacycloalkane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 09/01/2009 | US7582632 Tri(cyclo) substituted amide compounds |
| 09/01/2009 | US7582631 Paget's disease; muscular disorders; cardiovascular disorders; antiinflamamtory agents; antidiabetic agents; autoimmune disease; leukemia |
| 09/01/2009 | US7582630 N-[3-(trifluoromethyl)phenyl]-4-{2-[4-(trifluoromethyl)phenyl]pyrazolo[1,5-b]pyridazin-3-yl}pyrimidin-2-amine; enzyme inhibitors; inhibition/antagonism of protein kinases, glycogen synthase kinase-3-beta; central nervous system disorders; Alzheimer's disease; bipolar disorder; stroke; anticarcinogenic |
| 09/01/2009 | US7582629 2-tert-butyl-4-[(4-morpholin-4-ylphenyl)amino]-5-phenylisothiazol-3(2H)-one 1,1-dioxide; modulation of nuclear hormone receptors Liver X Receptor; cardiovascular diseases: atherosclerosis; antiinflammatory agent; Alzheimer's disease, antidiabetic agent; insulin resistance, metabolic disorders |
| 09/01/2009 | US7582628 Pyrrolo[3,4-c]pyrazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 09/01/2009 | US7582627 3-aminoquinazolin-2,4-dione antibacterial agents |
| 09/01/2009 | US7582626 N-{3-[1-(4-Fluoro-benzyl)-4-hydroxy-2-oxo-2,4a,5,6,7,7a-hexahydro-1H-[1]pyrindin-3-yl]-1,1-dioxo-1,4-dihydro-1 lambda 6-benzo[1,2,4]thiadiazin-7-yl}-methanesulfonamide;hepatitis C viral infections; hepatitis C NS5B polymerase inhibitors; enzyme inhibitors; viricides; side-effect reduction |
| 09/01/2009 | US7582625 -(4-Hydroxy-3,5-dimethyl-benzyl)-2-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-2-oxo-ethyl 4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidine-1-carboxylate; headaches; non-insulin dependent diabetes; antidiabetic agents; cardiovascular/nervous system disorders; antiinflammatory agents |
| 09/01/2009 | US7582624 Benzodiazepine derivatives and pharmaceutical compositions containing them |
| 09/01/2009 | US7582623 Photoactive metal nitrosyls for blood pressure regulation and cancer therapy |
| 09/01/2009 | US7582622 17a-Hydroxy-7,17a-dimethyl-D-homoestr-4-en-3-one; 7,17a-dimethyl-D-homoestr4-en-3-one; male hormone replacement therapy;androgen insufficiency; minimal risk of bone decalcification (trabecular bone mineral density (BMD) loss) and liver toxicity; androgen insufficency; oral administration |
| 09/01/2009 | US7582621 Topically treating ungal and periungal infections of the nails, hoofs and claws of mammals by treating with 1-hydroxy-5-fluoro-1,3-dihydro-2,1-benzoxyborole; effectively penetrates the nail; onychomycosis; tinea unguium; fungicides; viricides; bactericides; parasiticides; yeast; microbiocides |
| 09/01/2009 | US7582620 Use of mannan from saccharomyces cerevisiae for the treatment of asthma |
| 09/01/2009 | US7582619 Administering pyrimidine nucleotide precursor where respiratory chain dysfunction is caused by mutation, deletion, or rearrangement of mitochondrial DNA, cytotoxic cancer chemotherapy agents, aging |
| 09/01/2009 | US7582618 2′-C-methyl-3′-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections |
| 09/01/2009 | US7582617 Detecting modulators of binding protein activity; administering a radionuclide and a dose of at least one compound that is a selective partial A2A adenosine receptor agonist with a short duration of of action to a mammal in need thereof, and determining areas of insufficient blood flow |
| 09/01/2009 | US7582616 Nucleoside transport inhibitors |
| 09/01/2009 | US7582615 Antisense antiviral compound and method for treating arenavirus infection |
| 09/01/2009 | US7582614 Use of myxoma virus for the therapeutic treatment of cancer and chronic viral infection |
| 09/01/2009 | US7582613 Adjuvant compositions and methods for enhancing immune responses to polynucleotide-based vaccines |
| 09/01/2009 | US7582612 Multi-action anthelmintic formulations |
| 09/01/2009 | US7582611 Motilide compounds |
| 09/01/2009 | US7582448 nucleotide sequences coding protein of urogenital system for identifying modulators for treatment of cell proliferative and metastatic disorders |
| 09/01/2009 | US7582440 Imaging, diagnosis and treatment of disease |
| 09/01/2009 | US7582317 Food supplements comprising, as a health component, sargahydroquinoic acid or derivative thereof |
| 09/01/2009 | US7582315 Composition and method to augment and sustain neurotransmitter production |
| 09/01/2009 | US7582314 Such as psoriasis; a natural leukotriene inhibitor such as Boswellia serrata gum resin, or boswellic acid or derivatives, and an organic nutritional selenium source such as selenomethionine; no negative side effects; oral or topical administration dosage forms |
| 09/01/2009 | US7582313 Methods of organ regeneration using Hox 11-expressing pluripotent cells |
| 09/01/2009 | US7582311 Comprising hyaluronic acid or sodium hyaluronate dissolved in physiological buffer at concentration of 0.01-3 percent weight per volume and particles comprising first component biologically active agent and second component biocompatible polymeric matrix; use of 23-gauge or smaller bore needle |
| 09/01/2009 | US7582300 Modulation of gamma delta T cells to regulate airway hyperresponsiveness |
| 09/01/2009 | US7582297 Methods of treating respiratory conditions |
| 09/01/2009 | US7582289 administering to proliferating cells in a mammal having a Ras-activated pathway a viruse selected from modified adenovirus, modified HSV, modified vaccinia virus and modified parapoxvirus virus under conditions which result in lysis of neoplasmic cell |
| 09/01/2009 | US7582288 Methods of targeting multiple cytokines |
| 09/01/2009 | US7582287 Method for treating cervical cancer |
| 09/01/2009 | US7582282 Methods for optimizing clinical responsiveness to methotrexate therapy using metabolite profiling and pharmacogenetics |
| 09/01/2009 | CA2570329C Liposome preparation containing slightly water-soluble camptothecin |
| 09/01/2009 | CA2538019C Oral itraconazole composition which is not affected by ingested food and process for preparing same |
| 09/01/2009 | CA2520043C Novel galactooligosaccharide composition and the preparation thereof |
| 09/01/2009 | CA2506491C Novel derivatives of pyrrolidines and thiazolidines, process for preparing them and pharmaceutical compositions containing them |